Literature DB >> 29055746

Atrial fibrillation and arterial hypertension.

M S Kallistratos1, L E Poulimenos2, A J Manolis2.   

Abstract

Atrial fibrillation (AF) and arterial hypertension frequently coexist, not only because arterial hypertension increases the incidence of new onset of atrial fibrillation, but also because those two entities share common risk factors and conditions that increase the incidence of both. Thus, in our daily clinical practice we will often have to manage and treat those patients. In order to assess and treat these patients, proper blood pressure (BP) measurement as well as detection of atrial fibrillation is mandatory. The use of oscillometric devices for home and ambulatory blood pressure measurements may accurately measure systolic but not diastolic blood pressure levels. Current guidelines suggest to palpate the pulse and perform an electrocardiogram (ECG) as well as a long-term ECG monitoring in order to detect AF. However there is evidence that: the use of oscillometric BP device with a specific algorithm for the detection of AF as well as the interrogation of a permanent pacemaker may further help physicians to reveal periods of AF. Finnaly, although guidelines suggests the use of specific drugs in order to treat arterial hypertension in AF patients, the main goal is BP control per se. In this review, we are going to summarize the diagnostic work up of these patients namely the proper arterial blood pressure measurement, the detection of atrial fibrillation as well as the treatment of these patients based on the latest data of the literature.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Arterial hypertension; Atrial fibrillation; Detection; Treatment

Mesh:

Year:  2017        PMID: 29055746     DOI: 10.1016/j.phrs.2017.10.007

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  18 in total

1.  miR-455-5p regulates atrial fibrillation by targeting suppressor of cytokines signaling 3.

Authors:  Weiling Li; Na Qi; Shuo Wang; Wenyan Jiang; Tao Liu
Journal:  J Physiol Biochem       Date:  2021-04-01       Impact factor: 4.158

2.  Association between serum apolipoprotein B and atrial fibrillation: a case-control study.

Authors:  Xia Zhong; Huachen Jiao; Dongsheng Zhao; Jing Teng
Journal:  Sci Rep       Date:  2022-06-10       Impact factor: 4.996

Review 3.  Angiotensin Receptor Blocker and Calcium Channel Blocker Preventing Atrial Fibrillation Recurrence in Patients with Hypertension and Atrial Fibrillation: A Meta-analysis.

Authors:  Haotian Ma; Hongcheng Jiang; Jing Feng; Yong Gan
Journal:  Cardiovasc Ther       Date:  2021-05-17       Impact factor: 3.023

4.  Demographic, Clinical, and Angiographic Characteristics of Atrial Fibrillation Patients Suffering From de novo Acute Myocardial Infarction: A Subgroup Analysis of the MINOCA-TR Study Population.

Authors:  Ali Coner; Cenk Ekmekci; Gokhan Aydin; Yasemin Kilavuz Dogan; Ozlem Arican Ozluk; Salih Kilic; Yunus Celik; Ismail Ungan; Mustafa Begenc Tascanov; Ramazan Duz; Veli Polat; Hakan Ozkan; Mehmet Ozyasar; Kamil Tuluce; Abdullah Icli; Devrim Kurt; Nurullah Cetin; Murat Gul; Sinan Inci; Mehdi Zoghi; Oktay Ergene; Ugur Onsel Turk
Journal:  J Atr Fibrillation       Date:  2021-04-30

5.  Identification of two novel GATA6 mutations in an adult with acute myocardial infarction, diabetes, and atrial fibrillation: a case report.

Authors:  Zhao-Qing Sun; Ying-Hua Cui; Bo Yan
Journal:  J Geriatr Cardiol       Date:  2019-10       Impact factor: 3.327

6.  Upregulation of Transient Receptor Potential Canonical Type 3 Channel via AT1R/TGF-β1/Smad2/3 Induces Atrial Fibrosis in Aging and Spontaneously Hypertensive Rats.

Authors:  Rongfang He; Juan Zhang; Dan Luo; Yiyan Yu; Tangting Chen; Yan Yang; Fengxu Yu; Miaoling Li
Journal:  Oxid Med Cell Longev       Date:  2019-11-23       Impact factor: 6.543

7.  The Dose-Dependent Effects of Spironolactone on TGF-β1 Expression and the Vulnerability to Atrial Fibrillation in Spontaneously Hypertensive Rats.

Authors:  Mirong Tang; Yan Chen; Fuqing Sun; Liangliang Yan
Journal:  Cardiol Res Pract       Date:  2021-09-27       Impact factor: 1.866

Review 8.  Cardiac arrhythmias in arterial hypertension.

Authors:  Dimitrios Varvarousis; Manolis Kallistratos; Leonidas Poulimenos; Andreas Triantafyllis; Pavlos Tsinivizov; Andreas Giannakopoulos; Konstantinos Kyfnidis; Athanasios Manolis
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-08-09       Impact factor: 3.738

9.  Hypertrophic cardiomyopathies requiring more monitoring for less atrial fibrillation-related complications: a clustering analysis based on the French registry on hypertrophic cardiomyopathy (REMY).

Authors:  Marion Hourqueig; Guillaume Bouzille; Albert Hagège; Erwan Donal; Mariana Mirabel; Olivier Huttin; Thibaud Damy; Fabien Labombarda; Jean-Christophe Eicher; Philippe Charron; Gilbert Habib; Patricia Réant
Journal:  Clin Res Cardiol       Date:  2021-05-27       Impact factor: 5.460

10.  Declined ELABELA plasma levels in hypertension patients with atrial fibrillation: a case control study.

Authors:  Zheng Ma; Lei Zhao; Ye-Ping Zhang; Jiu-Chang Zhong; Xin-Chun Yang
Journal:  BMC Cardiovasc Disord       Date:  2021-08-12       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.